OLA1 is significantly overexpressed in HCC patients according to the TCGA database and CPTAC, which may offer valuable insights into the potential mechanisms underlying the elevation of anti-OLA1 autoantibody. The gene discussed is OLA1; the disease is hepatocellular carcinoma.